Related Articles
International Day of the Midwife 2024; reflecting on midwifery’s position in the global community in the era of climate change. – Evidence-Based Nursing blog
By Elizabeth Bailey, EBN’s Associate Editor for Midwifery and Women’s Health The 5th May marks International Day of the Midwife. This is an opportunity to…
Urology-Oncology Collaboration: Keys to Optimal Care in Metastatic Prostate Cancer – Damian Sorce & Manojkumar Bupathi
Alicia Morgans hosts a discussion with Damian Sorce, a urologist, and Manoj Bupathi, a medical oncologist, on their collaboration in treating patients with metastatic hormone-sensitive…
Biological clocks could be the key to longer, healthier lives. But scientists don’t yet agree on what ‘aging’ is
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
CAR T-Cells and Safety Signals | Intention to Treat
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript…
Higher BMI Linked to Respiratory, Renal Complications Post Lung Transplant
Researchers assessed the link between the pre-lung transplant BMI of recipients and donors and post-transplant complications in recipients.
Digestive Disease Week
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Digestive Disease Week
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Digestive Disease Week
Explore special articles published online first to coincide with presentations at the American Psychiatric Association Annual Meeting.
Measuring the return from pharmaceutical innovation 2024
Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and…
What you need to know about ‘game changer’ food allergy drug
The drug omalizumab, commonly used to treat asthma, nasal polyps, and hives, prevents severe reactions in people with food allergies.